Tourmaline Bio Inc. Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

Tourmaline Bio Inc. capital reinvestment ratio. Tourmaline Bio Inc. (TRML) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow ($11.02 Million) in capital expenditures ($2.00). Check TRML cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$11.02 Million

USD

Capital Expenditures

$2.00

USD

Data as of

Dec 2023

Most recent filing

Tourmaline Bio Inc. Capital Reinvestment Ratio by Year (None–None)

Tourmaline Bio Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see TRML cash generation efficiency.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow